DOCSLIB.ORG
  • Sign Up
  • Log In
  • Upload
  • Sign Up
  • Log In
  • Upload
  • Home
  • »  Tags
  • »  Tyloxapol

Tyloxapol

  • Symptomatic Pharmacotherapy in ALS: Data Analysis from a Platform-Based Medication Management Programme

    Symptomatic Pharmacotherapy in ALS: Data Analysis from a Platform-Based Medication Management Programme

  • WO 2016/074683 Al 19 May 2016 (19.05.2016) W P O P C T

    WO 2016/074683 Al 19 May 2016 (19.05.2016) W P O P C T

  • Marrakesh Agreement Establishing the World Trade Organization

    Marrakesh Agreement Establishing the World Trade Organization

  • Alphabetical Listing of ATC Drugs & Codes

    Alphabetical Listing of ATC Drugs & Codes

  • Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DIX to the HTSUS—Continued

    Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DIX to the HTSUS—Continued

  • (12) United States Patent (10) Patent No.: US 6,638,537 B2 Dennis Et Al

    (12) United States Patent (10) Patent No.: US 6,638,537 B2 Dennis Et Al

  • Supplementary File 2. Symptomatic Drugs Assigned to ALS Treatment

    Supplementary File 2. Symptomatic Drugs Assigned to ALS Treatment

  • Pharmacy Data Management Drug Exception List

    Pharmacy Data Management Drug Exception List

  • Bureau of Prisons Health Services 2018 Summer National Formulary (Part 2)

    Bureau of Prisons Health Services 2018 Summer National Formulary (Part 2)

  • Mucolytic Effectiveness of Tyloxapol in Chronic Obstructive Pulmonary Disease - a Double-Blind, Randomized Controlled Trial

    Mucolytic Effectiveness of Tyloxapol in Chronic Obstructive Pulmonary Disease - a Double-Blind, Randomized Controlled Trial

  • Electronic Supplementary Material

    Electronic Supplementary Material

  • Combined Index to USP 41 and NF 36, Volumes 1–5

    Combined Index to USP 41 and NF 36, Volumes 1–5

  • Symptomatic Pharmacotherapy in ALS: Data Analysis from a Platform-Based Medication Management Programme

    Symptomatic Pharmacotherapy in ALS: Data Analysis from a Platform-Based Medication Management Programme

  • Combined Index to USP 42 and NF 37, Volumes 1–5, Including Second Supplement

    Combined Index to USP 42 and NF 37, Volumes 1–5, Including Second Supplement

  • Business Impact Analysis

    Business Impact Analysis

  • Atc Index 2010

    Atc Index 2010

  • Gpi Drug Classification Report

    Gpi Drug Classification Report

  • A Pharmaceutical Composition Comprising a Menthane Carboxylic Acid Amide

    A Pharmaceutical Composition Comprising a Menthane Carboxylic Acid Amide

Top View
  • ATC-Index Mit DDD-Angaben Für Den Deutschen Arzneimittelmarkt Berlin 2013, 12
  • ATC-Index Mit DDD-Angaben Für Deutschland Im Jahre 2019
  • „ Wo 2012/012498 A2
  • Repurposing of Drugs As Novel Influenza Inhibitors from Clinical Gene
  • A Full Cycle Anti-Viral Drug Screen Identifies a Clinical Compound
  • Australian Statistics on Medicines 2009
  • Aerosol Therapy in Pulmonary Critical Care
  • Excipients in the Paediatric Population: a Review
  • Title 21 Food and Drugs Parts 300 to 499
  • Evaluating the Need for an Orphan Drug Act in India by Comparing It with the US Orphan
  • Drugs Used in the Treatment of the Common Cold
  • A Small Molecule Drug Screening Identifies Colistin Sulfate As an Enhancer of Natural Killer
  • Gold Standard Drug Monographs
  • U.S. EQUINE Zoetis EQUINE Products ANTI-INFLAMMATORIES
  • (12) Patent Application Publication (10) Pub. No.: US 2009/0098207 A1 Malakhov Et Al
  • To USP 39–NF 34, Second Supplement the Following Index Is
  • [Ehdsi V3.0.0-RC1] Ehealth DSI – Master Value Set Catalogue
  • Rank Cmap Name 1 Trichostatin a 2 Piribedil 3 Omeprazole 4 MS-275 5 Penbutolol 6 Calcium Folinate 7 Phthalylsulfathiazole 8 Clop


© 2024 Docslib.org    Feedback